• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community.

作者信息

Aide Nicolas, Fanti Stefano

机构信息

Nuclear Medicine Department, Caen University hospital, avenue côte de nacre, 14000, Caen, Basse Normandie, France.

INSERM U1086 ANTICIPE, Normandy University, Caen, France.

出版信息

Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):1-3. doi: 10.1007/s00259-017-3721-5. Epub 2017 May 24.

DOI:10.1007/s00259-017-3721-5
PMID:28540418
Abstract
摘要

相似文献

1
Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):1-3. doi: 10.1007/s00259-017-3721-5. Epub 2017 May 24.
2
Positron emission tomography: current status and future challenges.正电子发射断层扫描：现状与未来挑战。
Intern Med J. 2010 Jan;40(1):19-29. doi: 10.1111/j.1445-5994.2009.02072.x.
3
Predicting therapy outcome with quantitative PET: what is needed and what can be done?
Onkologie. 2009 Dec;32(12):706-7. doi: 10.1159/000258150. Epub 2009 Nov 20.
4
Maximising the benefit of integrated PET/CT: the road ahead.
Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1462-3. doi: 10.1007/s00259-004-1685-8. Epub 2004 Oct 5.
5
[Positron emission tomography (PET)--current state of the art and future perspectives].
Praxis (Bern 1994). 2005 Aug 31;94(35):1331-7. doi: 10.1024/0369-8394.94.35.1331.
6
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.正电子发射断层显像/计算机断层扫描（PET/CT）成像用于评估去势抵抗性前列腺癌的治疗反应
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2103-2104. doi: 10.1007/s00259-016-3493-3.
7
Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.技术洞察：分子成像进展及正电子发射断层扫描/计算机断层扫描（PET/CT）的评估
Nat Clin Pract Oncol. 2008 Mar;5(3):160-70. doi: 10.1038/ncponc1041.
8
Immuno-PET: a navigator in monoclonal antibody development and applications.免疫正电子发射断层显像：单克隆抗体研发与应用的导航工具
Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379.
9
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.Cochrane关于脑[¹⁸F]FDG PET在痴呆症中的综述：局限性与未来展望。
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1487-91. doi: 10.1007/s00259-015-3098-2.
10
(18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.（18）18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在实体瘤治疗反应评估中的应用：现状与展望
Q J Nucl Med Mol Imaging. 2011 Dec;55(6):620-32.

本文引用的文献

1
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.利用最先进的正电子发射断层扫描（PET）对小病灶检测进行量化、改进和标准化。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):4-16. doi: 10.1007/s00259-017-3727-z. Epub 2017 Jul 8.
2
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.EANM/EARL在PET定量分析中的协调策略：从日常实践到多中心肿瘤学研究。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):17-31. doi: 10.1007/s00259-017-3740-2. Epub 2017 Jun 16.
3
Therapy assessment in multiple myeloma with PET.
利用正电子发射断层显像（PET）对多发性骨髓瘤进行治疗评估。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):111-117. doi: 10.1007/s00259-017-3730-4. Epub 2017 Jun 1.
4
Therapy assessment of bone metastatic disease in the era of radium.镭时代骨转移性疾病的治疗评估
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):84-96. doi: 10.1007/s00259-017-3734-0. Epub 2017 May 31.
5
Therapy assessment in prostate cancer using choline and PSMA PET/CT.使用胆碱和PSMA PET/CT对前列腺癌进行治疗评估。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):78-83. doi: 10.1007/s00259-017-3723-3. Epub 2017 May 25.
6
Using PET for therapy monitoring in oncological clinical trials: challenges ahead.在肿瘤学临床试验中使用正电子发射断层扫描（PET）进行治疗监测：未来的挑战。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):32-40. doi: 10.1007/s00259-017-3689-1. Epub 2017 Apr 27.
7
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.用于霍奇金淋巴瘤和非霍奇金淋巴瘤治疗监测的氟代脱氧葡萄糖正电子发射断层显像（FDG PET）
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14.
8
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.前列腺癌中使用放射性标记胆碱的PET及PET/CT：对20年临床研究的批判性重新评估
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1751-1776. doi: 10.1007/s00259-017-3700-x. Epub 2017 Apr 14.
9
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.癌症的分子靶向治疗：核医学医师指南
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):41-54. doi: 10.1007/s00259-017-3695-3. Epub 2017 Apr 10.
10
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.在靶向治疗药物和免疫治疗时代，使用氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG PET/CT）进行黑色素瘤疗效评估的优势与挑战
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):67-77. doi: 10.1007/s00259-017-3691-7. Epub 2017 Apr 7.